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Background: We have established delivery and dosing protocols for optimal engraftment of cardiospheres (CSps) using Myostar® injection 
catheter-guided cell transplantation. A randomized, blinded, placebo-controlled study was performed to test safety and efficacy of dose-optimized 
CSp injection in porcine chronic ischemic cardiomyopathy (ICM).
methods: Allogeneic CSps were grown from a donor farm pig. Adult Yucatan mini-pigs (n=22), fully mismatched for swine leukocyte antigens, served 
as recipients. Mini-pigs sustained 3h LAD balloon occlusion and reperfusion. Eight weeks later, pigs underwent electromechanical mapping of the LV 
(NOGA®) and were randomized to receive 15 transendocardial injections of allogeneic CSps (150x106 cells) or vehicle into the infarct border zone. 
Full bloodwork, flow cytometry and cardiac histology were performed to evaluate safety. MRI was performed before injection and eight weeks later to 
evaluate efficacy.
results: There were no deaths in either arm. Serum ANP increased only in control pigs. Flow cytometry detected no donor specific antibodies. 
Histology demonstrated no signs of immune rejection. MRI revealed reduced scar size (Fig A), increased viable mass (Fig B), and preserved cardiac 
morphology (Fig C, D) with CSp injection compared to placebo.
conclusion: Percutaneous transendocardial delivery of allogeneic CSps is safe and effective in porcine ICM. The decreases in scar size, mirrored by 
increases in viable myocardium, indicate genuine regeneration.
 
